How Effective Is Pharmacovigilance? EMA Committee Intends To Find Out
This article was originally published in SRA
The European Medicines Agency is planning a number of measures to evaluate the concrete effects of pharmacovigilance activities with a view to determining which actions are most effective and what needs to be done to improve the collection and utilization of drug safety data in the EU1.
You may also be interested in...
While the EU attempts to accelerate the pace of its unified approach to vaccine roll-out, some eastern European countries are taking their own decisions.
The pharmaceutical industry and other stakeholders have taken part in the launch event for a new initiative intended to tackle issues that have been amplified by the COVID-19 pandemic, such as supply chain resilience and medicine shortages. The project has drawn a mixed response from industry bodies.
The MHRA is losing no time in getting its much heralded “new era” of medicines regulation up and running.